Xinlan Liu

879 total citations
42 papers, 465 citations indexed

About

Xinlan Liu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinlan Liu has authored 42 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinlan Liu's work include HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (7 papers) and Breast Cancer Treatment Studies (6 papers). Xinlan Liu is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (7 papers) and Breast Cancer Treatment Studies (6 papers). Xinlan Liu collaborates with scholars based in China, United States and Japan. Xinlan Liu's co-authors include Yanyang Wang, Ren Zhao, Ang Chen, Zhendong Niu, Xueping Peng, Sheng Huang, Tao Zhang, Ji Ma, Qing‐Li Zhao and Yongmei Cui and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xinlan Liu

36 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinlan Liu China 9 240 97 80 77 59 42 465
Xing Huang China 12 180 0.8× 102 1.1× 89 1.1× 73 0.9× 54 0.9× 37 519
Linfeng Zheng China 15 131 0.5× 52 0.5× 68 0.8× 118 1.5× 66 1.1× 37 522
Xinyu Ma China 15 316 1.3× 68 0.7× 82 1.0× 102 1.3× 31 0.5× 58 635
Run Huang China 14 283 1.2× 111 1.1× 218 2.7× 190 2.5× 45 0.8× 34 739
Fahad Munir China 14 438 1.8× 59 0.6× 54 0.7× 53 0.7× 98 1.7× 22 795
Nataša Pavlović Sweden 13 93 0.4× 42 0.4× 58 0.7× 85 1.1× 51 0.9× 29 474
Menglin Xu China 15 268 1.1× 90 0.9× 116 1.4× 119 1.5× 42 0.7× 62 631
Yujia Zhao China 11 153 0.6× 75 0.8× 61 0.8× 82 1.1× 51 0.9× 34 392
Niren Kapoor United States 12 337 1.4× 45 0.5× 109 1.4× 21 0.3× 36 0.6× 23 765

Countries citing papers authored by Xinlan Liu

Since Specialization
Citations

This map shows the geographic impact of Xinlan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlan Liu more than expected).

Fields of papers citing papers by Xinlan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinlan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlan Liu. The network helps show where Xinlan Liu may publish in the future.

Co-authorship network of co-authors of Xinlan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinlan Liu. A scholar is included among the top collaborators of Xinlan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinlan Liu. Xinlan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xinlan, et al.. (2025). D‐Mannose Upregulates Testin via the NF‐κB Pathway to Inhibit Breast Cancer Proliferation. Journal of Biochemical and Molecular Toxicology. 39(8). e70398–e70398.
4.
Yuan, Wenjuan, Xinlan Liu, Cheng‐Ting Zi, et al.. (2025). Evaluating the Components, Nutrients, and Antioxidant and Anti-Inflammatory Properties of Centranthera grandiflora Benth Extracts. Nutrients. 17(5). 925–925.
5.
Yan, Min, Xinlan Liu, Shusen Wang, et al.. (2025). Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases. JAMA Oncology. 11(8). 883–883. 1 indexed citations
6.
Shen, Xiaojing, Xinting Wang, Xinlan Liu, et al.. (2024). HPLC and LC–MS/MS-Based Quantitative Characterization of Related Substances Associated with Sotalol Hydrochloride. Molecules. 29(3). 588–588. 1 indexed citations
7.
Zhang, Guoxin, Qiuxia Dong, Qianqian Fang, et al.. (2024). Nomogram for predicting the risk and prognosis of lung metastasis of four subtypes of breast cancer: A population-based study from SEER. SHILAP Revista de lepidopterología. 3(2). 154–162. 2 indexed citations
8.
Yang, Yupeng, et al.. (2023). Construction of NiP/Ni(OH)2/Ag-ZIF photocatalyst with 2-methylimidazole framework for rapid removal of tetracycline. Colloids and Surfaces A Physicochemical and Engineering Aspects. 683. 132997–132997. 3 indexed citations
9.
Li, Jinming, Guoshuang Shen, Zhen Liu, et al.. (2023). Treatment‐related adverse events of antibody‐drug conjugates in clinical trials: A systematic review and meta‐analysis. SHILAP Revista de lepidopterología. 2(5). 346–375. 6 indexed citations
10.
Yuan, Wenjuan, Xinlan Liu, Cheng‐Ting Zi, et al.. (2023). Steroidal Alkaloids from the Roots of Veratrum mengtzeanum Loes. with Their Anti-Inflammatory Activities. Molecules. 28(20). 7116–7116. 2 indexed citations
11.
Shen, Guoshuang, Qiqi Xie, Xinlan Liu, et al.. (2023). Development of Tumor Markers for Breast Cancer Immunotherapy. Current Molecular Medicine. 24(5). 547–564. 2 indexed citations
12.
Liu, Zhen, et al.. (2023). Survival nomogram for patients with de novo metastatic breast cancer based on the SEER database and an external validation cohort. SHILAP Revista de lepidopterología. 1(4). 253–261. 2 indexed citations
13.
Wei, Tingting, Zhisheng Wang, & Xinlan Liu. (2023). Adverse reactions and efficacy of camrelizumab in patients with lung adenocarcinoma with high PD-L1 expression: A case report. Medicine. 102(7). e32731–e32731. 3 indexed citations
15.
Wang, Yanyang, Xinlan Liu, & Ren Zhao. (2019). Induction of Pyroptosis and Its Implications in Cancer Management. Frontiers in Oncology. 9. 971–971. 182 indexed citations
16.
Duan, Xiangguo, Jing Bai, Jun Wei, et al.. (2017). MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase-associated protein 2. Molecular Medicine Reports. 16(2). 2163–2171. 14 indexed citations
17.
Ma, Ji, et al.. (2017). The anti-tumor effect of aspirin: What we know and what we expect. Biomedicine & Pharmacotherapy. 95. 656–661. 42 indexed citations
18.
Zhang, Wenming, Teng Yang, Xinlan Liu, et al.. (2016). The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: modifications at C12 and C7. European Journal of Medicinal Chemistry. 127. 917–927. 23 indexed citations
19.
Liu, Xinlan. (2013). Effects of VEGF-C, VEGFR-3 and LYVE-1 on Lymphangiogenesis and Prognosis in Gastric Cancer. 2 indexed citations
20.
Liu, Xinlan. (2011). Effects of nitrogen management on maize dry matter accumulation,nitrogen uptake and distribution and maize yield. Plant Nutrition and Fertilizing Science. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026